IQV

Q: What is the price of IQVIA Holdings (IQV) today?

The price of IQVIA Holdings (IQV) today is R$ 1.021,41, with a variation of -24.25% compared to the last year. The price of IQVIA Holdings (IQV) started the year trading around R$ 1.069,01 and today it is at R$ 1.021,41. Follow the real-time price chart, the historical price of IQVIA Holdings (IQV), and stock data from Ibovespa and international markets.

Q: When does IQVIA Holdings (IQV) pay dividends?

IQVIA Holdings (IQV) did not distribute dividends in the last year.

Q: IQVIA Holdings (IQV) is it worth it?

Currently, IQVIA Holdings (IQV) is priced at R$ 1.021,41, with a P/E of 26,58%, representing a deviation of 35,32% from its historical average P/E. In the last year, the stock showed a variation of -24.25% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -24,25%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of IQVIA Holdings (IQV)?

Investing in shares of IQVIA Holdings (IQV) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of IQVIA Holdings (IQV) yield today?

The yield of IQVIA Holdings (IQV) was -5,73% in the last month, -24,25% in the last year and 16,46% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of IQVIA Holdings (IQV) today, the total investment would be based on the current price of R$ 1.021,41.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 77.372,14In 5 years: R$ 118.953,92In 10 years: 257.386,21It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IQVIA Holdings Inc.

Price

US$ 187,76

variation (12m)

-24,25%

p/l

26,58

p/vp

5,68

DIVIDEND YIELD

0,00%

quote IQV

BVMF

IQV

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of IQV

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-5,73%

3 months

35,29%

1 year

-24,25%

2 years

-14,25%

5 years

16,46%

10 years

151,99%

real profitability

profitability minus inflation.

1 month

-5,73%

3 months

34,62%

1 year

-28,03%

2 years

-21,84%

5 years

-14,90%

10 years

49,39%

Indicators IQV

check out the fundamentals of IQVIA Holdings shares

P/L

26,58

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

2,09

Sector: 1,99 Industry: 2,90

P/VP

5,68

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

4,32%

Sector: -26,53% Industry: -56,94%

ROE

21,38%

Sector: -31,21% Industry: -45,34%

ROIC

6,94%

Sector: -404,40% Industry: -420,46%

Net Margin

7,88%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

34,25%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

14,41%

Sector: -23,10% Industry: -30,21%

P/EBITDA

9,82

Sector: 0,07 Industry: -2,60

P/EBIT

14,76

Sector: -1,37 Industry: -3,22

P/ASSETS

1,15

Sector: 1,23 Industry: 1,32

VPA

33,64

Sector: 3,66 Industry: 1,68

LPA

7,19

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,20

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

6,69%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

34,70%

Sector: - Industry: -

FAIR PRICE OF IQVIA Holdings ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 187,76

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-60,71%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

IQV indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of IQV with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history IQV dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY IQVIA Holdings

IQVIA Holdings Inc.

Average user rating I10

4.0 (2 people)

Estados Unidos

43 years

Foundation: 1982

2013

Year of debut on the stock exchange - 12 years

79.000

Employees

The Company IQVIA Holdings Inc. (Estados Unidos), is listed on NYSE with a market value of $ 32,88 Billions, having a net worth of $ 5,79 Billions.

With a total of 79.000 employees, the company is listed in the sector of Saúde and categorized in industry of Ferramentas e Serviços de Ciências da Vida.

In the last 12 months the Company had a revenue of $ 15,70 Billions, which generated a profit in the amount of $ 1,24 Billion.

As for its main indicators, the Company has a P/E ratio of 26,58, a P/B ratio of 5,68 and in the last 12 months the Company did not pay dividends.

The Company is traded in Brazil through the BDR I1QV34, or can be purchased on abroad through the ticker IQV.

Market value

US$ 32,88 Billions

Net worth

US$ 5,79 Billions

US$ 5.786.000.000,00

Assets

US$ 28,63 Billions

US$ 28.632.000.000,00

Total Number of Shares

172,00 Milhões

172.000.000

Average Daily Trading Volume

US$ 1,98 Million

US$ 1.976.278,00

Sector

Saúde

Industry

Ferramentas e Serviços de Ciências da Vida

IQV

IQV revenue and profits

IQV results

DRAG THE FRAME TO SEE MORE DATA

IQV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of IQVIA Holdings (IQV) today?

The price of IQVIA Holdings (IQV) today is R$ 1.021,41, with a variation of -24.25% compared to the last year. The price of IQVIA Holdings (IQV) started the year trading around R$ 1.069,01 and today it is at R$ 1.021,41. Follow the real-time price chart, the historical price of IQVIA Holdings (IQV), and stock data from Ibovespa and international markets.

When does IQVIA Holdings (IQV) pay dividends?

IQVIA Holdings (IQV) did not distribute dividends in the last year.

IQVIA Holdings (IQV) is it worth it?

Currently, IQVIA Holdings (IQV) is priced at R$ 1.021,41, with a P/E of 26,58%, representing a deviation of 35,32% from its historical average P/E. In the last year, the stock showed a variation of -24.25% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -24,25%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of IQVIA Holdings (IQV)?

Investing in shares of IQVIA Holdings (IQV) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of IQVIA Holdings (IQV) yield today?

The yield of IQVIA Holdings (IQV) was -5,73% in the last month, -24,25% in the last year and 16,46% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of IQVIA Holdings (IQV) today, the total investment would be based on the current price of R$ 1.021,41.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 77.372,14
In 5 years: R$ 118.953,92
In 10 years: 257.386,21

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IQV

IQVIA Holdings Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of IQV

check out the fundamentals of IQVIA Holdings shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY IQVIA Holdings

IQVIA Holdings Inc.

Estados Unidos

43 years

2013

79.000

PROFIT X PRICE IQV

IQV results

IQV cash flow

evolution of assets - IQV

IQV balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80